logging in or signing up safety of intracameral moxifloxacin after cataract. surgery drpravindesh Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 171 Category: Science & Tech.. License: All Rights Reserved Like it (0) Dislike it (0) Added: November 24, 2010 This Presentation is Public Favorites: 2 Presentation Description IT was done to assess the safety of intracameral moxifloxacin after cataract surgery and was presented in KSOC 2010 Comments Posting comment... Premium member Presentation Transcript Assessment of safety of Intracameral Moxifloxacin in Cataract surgery : Assessment of safety of Intracameral Moxifloxacin in Cataract surgery AUTHOR-DR PRAVEEN DESHPANDE POST GRADUATE COAUTHOR- DR MANOHAR MEHTA, DR G. PAVAN Department Of Ophthalmology VIMS, Bellary PRAVEEN Deshpande PURPOSE : PURPOSE To assess the effect of intracameral Moxifloxacin anterior chamber reaction endothelial cell count corneal thickness MATERIALS : MATERIALS Moxifloxacin- 0.5% eye drops Broad spectrum Rapidly bactericidal Improved penetration Preservative free Slide 4: ph of 6.8 osmolality of 290 mOsm/kg Higher AH conc above MIC Better MIC in vitreous METHOD : METHOD Prospective study No. of cases- 50 patients Exclusion criteria : Exclusion criteria Hypermature cataract Cataract a/w other ocular abnormality Slide 7: Preoperative assessment Routine ocular examination - Nucleus grading ( LOCS III) - Endothelial cell counts* - corneal thickness Procedure : Procedure small incision cataract surgery with PCIOL 0.1 mL of 0.5% moxifloxacin (500 μ g) solution injected intracamerally at the end of the surgery. Video : Video Slide 10: Postoperative assessment The patients - follow-up 1 day, 1 week, and 1 month after surgery. Slide 11: Results : Results 50 patients completed the study. The mean endothelial cell count - preoperatively - 2378 cells/mm2 postoperatively - 2164 cells/mm2 Mean difference- 214cells/mm2, which not statistically significant The mean pachymetry preoperatively - 0.489 mm postoperatively- 0.503 mm The increase of 0.14 mm in postoperative pachymetry after 1 month. Mean age : Mean age Specular Microscopy : Specular Microscopy Pre-op Post-op Endothelial cell count ( normal-4-15%) ( n-50, p>0.05) : Endothelial cell count ( normal-4-15%) ( n-50, p>0.05) Corneal thickness (n-50, p>0.05) : Corneal thickness (n-50, p>0.05) AC cells : AC cells Visual acuity : Visual acuity Conclusion : Conclusion Nontoxic Safe for prophylaxis in cataract surgery References : References J Cataract Refract Surg. 2007;33:978–988 J Cataract Refract Surg. 2007;33:1801–1805 Journal of Cataract & Refractive Surgery June 2002 (Vol. 28, Issue 6, Pages 982-987) J Cataract Refract Surg 1998; 24:725–726 Journal of Cataract & Refractive Surgery .January 2007 (Vol. 33, Issue 1, Pages 63-68) Slide 22: Thank you You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
safety of intracameral moxifloxacin after cataract. surgery drpravindesh Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 171 Category: Science & Tech.. License: All Rights Reserved Like it (0) Dislike it (0) Added: November 24, 2010 This Presentation is Public Favorites: 2 Presentation Description IT was done to assess the safety of intracameral moxifloxacin after cataract surgery and was presented in KSOC 2010 Comments Posting comment... Premium member Presentation Transcript Assessment of safety of Intracameral Moxifloxacin in Cataract surgery : Assessment of safety of Intracameral Moxifloxacin in Cataract surgery AUTHOR-DR PRAVEEN DESHPANDE POST GRADUATE COAUTHOR- DR MANOHAR MEHTA, DR G. PAVAN Department Of Ophthalmology VIMS, Bellary PRAVEEN Deshpande PURPOSE : PURPOSE To assess the effect of intracameral Moxifloxacin anterior chamber reaction endothelial cell count corneal thickness MATERIALS : MATERIALS Moxifloxacin- 0.5% eye drops Broad spectrum Rapidly bactericidal Improved penetration Preservative free Slide 4: ph of 6.8 osmolality of 290 mOsm/kg Higher AH conc above MIC Better MIC in vitreous METHOD : METHOD Prospective study No. of cases- 50 patients Exclusion criteria : Exclusion criteria Hypermature cataract Cataract a/w other ocular abnormality Slide 7: Preoperative assessment Routine ocular examination - Nucleus grading ( LOCS III) - Endothelial cell counts* - corneal thickness Procedure : Procedure small incision cataract surgery with PCIOL 0.1 mL of 0.5% moxifloxacin (500 μ g) solution injected intracamerally at the end of the surgery. Video : Video Slide 10: Postoperative assessment The patients - follow-up 1 day, 1 week, and 1 month after surgery. Slide 11: Results : Results 50 patients completed the study. The mean endothelial cell count - preoperatively - 2378 cells/mm2 postoperatively - 2164 cells/mm2 Mean difference- 214cells/mm2, which not statistically significant The mean pachymetry preoperatively - 0.489 mm postoperatively- 0.503 mm The increase of 0.14 mm in postoperative pachymetry after 1 month. Mean age : Mean age Specular Microscopy : Specular Microscopy Pre-op Post-op Endothelial cell count ( normal-4-15%) ( n-50, p>0.05) : Endothelial cell count ( normal-4-15%) ( n-50, p>0.05) Corneal thickness (n-50, p>0.05) : Corneal thickness (n-50, p>0.05) AC cells : AC cells Visual acuity : Visual acuity Conclusion : Conclusion Nontoxic Safe for prophylaxis in cataract surgery References : References J Cataract Refract Surg. 2007;33:978–988 J Cataract Refract Surg. 2007;33:1801–1805 Journal of Cataract & Refractive Surgery June 2002 (Vol. 28, Issue 6, Pages 982-987) J Cataract Refract Surg 1998; 24:725–726 Journal of Cataract & Refractive Surgery .January 2007 (Vol. 33, Issue 1, Pages 63-68) Slide 22: Thank you